Product description：Buy Cheap Cardarine powder online, gw 501516 sarm powder,buy gw 501516 powder china,cardarine sarm powder for sale, raw sarm powder china,sarm powder suppliers,sarm powders for sale china
gw 501516 Cardarine Powder cardarine gw 50156 for sale Chemical Name: GW 501516 CAS No.:317318-70-0 Keyword:GW-501516; Cardarine GW501516; Acetic acid Molecular Formula:C21H18F3NO3S2 Molecular Weight:453.4977 Storage:Store at Room temperature Purity:99% min Appearance:White to off white powder Shelf life:2 years when properly stored Cardarine GW501516 (also known as GW1516, GSK-516 and Endurobol) is a PPAR receptor. It activates the same pathways activated through exercise, including PPAR and AMP- activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound alone. GW 501516 (Cardarine) is one of the most versatile performance enhancers one will ever come across. Whether you are looking to drastically increase endurance, melt fat, cut or recomp, GW will truly shine. In this article, I am going to touch on the many ways and reason to incorporate GW into every cycle that you run. There is a place for GW in every cycle, regardless of the desired goal. It can only add extra benefits that will further enhance the chances of accomplishing goals and maximizing gains
GW-501516 is a unique medication officially classified as a PPAR receptor agonist (PPAR-RA). Research for this medication began in 1992 in a conjoined effort between GlaxoSmithKline (GSK) and Ligand Pharmaceuticals. Research into this product was set forth in an effort to provide treatment for various cardiovascular diseases, as well as diabetes, obesity and other conditions. It was soon discovered that the PPAR-RA was highly effective at enhancing endurance, but it was also shown to carry a high potential cost. It was discovered that GW-501516 increased the chances of cancer significantly, and as a result, GSK dropped all further research. However, the studies that produced cancerous results used doses of GW-501516 that were 500 to even 1000 times the amount that a human being would take. If cancer is a risk with standard dosing is unknown.
Usage: It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 could be used by athletes as an ergogenic performance enhancing